QID 373312

Date Published: 2021-05-13

QID 373312: IBM Sterling B2B Integrator Multiple security Vulnerabilities

IBM Sterling B2B Integrator helps companies integrate all their complex B2B/EDI processes across their partner communities in a single gateway. FasterXML jackson-databind in IBM b2b integrator could allow a remote attacker to execute arbitrary code on the system, caused by an unsafe deserialization when using the xalan JNDI gadget. By sending specially-crafted input, an attacker could exploit this vulnerability to execute arbitrary code on the system.

Affected Versions:
IBM Sterling B2B Integrator 5.2.6.2 - 6.0.3.1

QID Detection Logic:(Authenticated)
This QID checks the vulnerable version of IBM B2B installed and checks if patch is applied or not.

Successful exploitation allows a remote attacker to execute arbitrary code on the system, caused by an unsafe deserialization when using the xalan JNDI gadget. By sending specially-crafted input, an attacker could exploit this vulnerability to execute arbitrary code on the system.

CVSS V3 rated as Critical - 9.8 severity.

CVSS V2 rated as High - 7.5 severity.

Solution

Customers are advised to apply B2B Integrator fix pack 5.2.6.5_2 or 6.0.3.2 to fix this vulnerability. More information can be found CVE-2019-14892, CVE-2019-14893.

Vendor References

CVE-2019-14892, CVE-2019-14893 - www.ibm.com/support/pages/node/6210298

CVEs related to QID 373312

CVE-2019-14892 | CVE-2019-14893 |

Software Advisories

Advisory ID	Software	Component	Link
CVE-2019-14892, CVE-2019-14893			www.ibm.com/support/pages/node/6210298

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].